Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.
Faulty Genes May Prove the Root Cause of Allergies
Research shows that defective genes known to play a role in connective tissue disorders also plays a significant role in the development of allergies and points to a possible treatment.
AANMA Maps the Status of State Epinephrine Legislation
The AANMA maintains the status of state stock epinephrine legislation in an easy to reference US map. Their site provides links to ACE volunteers in each state that provide education, advocacy and outreach.
$25 Auvi-Q Copay Program
Sanofi has instituted a $25 copay program for the purchase of up to two Auvi-Q epinephrine auto-injectors.
Understand the Limitations of the Label
Knowing what the label CAN and CAN'T tell you about the allergen safety of a food product is an important step toward safeguarding your family.
Update to Safe Snack Guide: July 11, 2013
We've added a number of new products and have confirmed the manufacturing processes of a number of existing products via our Manufacturers' Product Portal which is currently in beta test.
A Preview of the SnackSafely.com Manufacturer Partnership Initiative
SnackSafely.com has been developing a platform that will allow us to engage directly with manufacturers to learn much more about how their products are produced.
Update on Allergen Immunotherapy
The American Academy of Allergy, Asthma and Immunology and the European Academy of Allergy and Clinical Immunology have issued a consensus report on the current state of allergen immunotherapy.
Nip/Tuck
We got a little nip/tuck here and there over the weekend so you may notice a few cosmetic changes in our site.
Update to Safe Snack Guide: May 31, 2013
Please note that we have removed two items from the Safe Snack Guide.
School Access to Emergency Epinephrine Bill Reintroduced to Congress
The School Access to Emergency Epinephrine Act was reintroduced Wednesday. Show your support!
